comparemela.com
Home
Live Updates
Claude Mikkelsen - Breaking News
Pages:
4
5
6
7
8
9
10
Latest Breaking News On - Claude mikkelsen - Page 3 : comparemela.com
EQS-News: BB BIOTECH AG: Divergent biotech equity markets mirror value over growth theme in 2022 Proposed dividend of CHF 2 85
EQS-News: BB Biotech AG / Key word(s): Annual Results/Dividend BB BIOTECH AG: Divergent biotech equity markets mirror value over grow.
Sumitomo pharma
Neurocrine biosciences
Tanja chicherio
Claude mikkelsen
Pearl huang
Silvia siegfried schanz
Laura hamill
Thomas egger
Maria grazia alderuccio
Essa pharma
Scholar rock holding
Alnylam pharmaceuticals
Generation bio co
Kezar life sciences
Radius health
Dow jones
DGAP-News: BB BIOTECH AG: Moderna was just the beginning
DGAP-News: BB Biotech AG / Key word(s): Market Report BB BIOTECH AG: Moderna was just the beginning 30.08.2022 / 11:00 The.
Ionis pharma
Tanja chicherio
Claude mikkelsen
Daniel koller
Silvia schanz
Maria grazia alderuccio
Swiss federal institute of technology
Head investment management team
Head of investment management team bb biotech
Wave life sciences
Bellevue asset
Bellevue asset management
Portfolio manager
Investment management team
Asset management
Swiss federal institute
Investegate |BB BIOTECH AG Announcements | BB BIOTECH AG: First signs of increased M&A activity due to attractive valuations
Investegate announcements from BB BIOTECH AG, First signs of increased M&A activity due to attractive valuations
Neurocrine biosciences
Thomas egger
Tanja chicherio
Claude mikkelsen
Essa pharma
Maria grazia alderuccio
Silvia siegfried schanz
Vertex pharmaceuticals
Nektar therapeutics
Ute communications
Agios pharmaceuticals
Myovant sciences
Scholar rock holding
Alnylam pharmaceuticals
World health care index
Celldex therapeutics
BB BIOTECH AG: Disruptive technologies are changing an entire industry
24.05.2022 BB BIOTECH AG: Disruptive technologies are changing an entire industry | BB BIOTECH AG | News | Nachricht | Mitteilung
United states
Tanja chicherio
Claude mikkelsen
Daniel koller
Maria grazia iten alderuccio
Silvia siegfried schanz
Swiss federal institute of technology
Head investment team
Bellevue asset
Vertex pharma
Relay therapeutics
Diamond therapeutics
Bellevue asset management
Swiss federal institute
Grazia iten alderuccio
D hoc
DGAP-News: BB BIOTECH AG: Disruptive technologies are changing an entire industry
DGAP-News: BB BIOTECH AG: Disruptive technologies are changing an entire industry
United states
Tanja chicherio
Claude mikkelsen
Daniel koller
Maria grazia iten alderuccio
Silvia siegfried schanz
Swiss federal institute of technology
Head investment team
Bellevue asset
Vertex pharma
Relay therapeutics
Diamond therapeutics
Bellevue asset management
Swiss federal institute
Grazia iten alderuccio
vimarsana © 2020. All Rights Reserved.